NCT05029349

Exploration of the VOLATOLOM in the Stable Severe COPD (Chronic Obstructive Pulmonary Disease)

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Hopital Foch · Academic / Other
• Sex: All
• Age: 40 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective interventional study to determine whether the profile of volatile organic compounds (VOCs) present in exhaled air (VOLATOLOM) is reproducible in stable severe COPD (Chronic Obstructive Pulmonary Disease) patients.

Detailed description

After being informed about the study, all patients giving written informed consent and meeting the eligibility criteria will undergo 4 visits spaced 4 to 6 weeks apart. The first visit V1 will be about 45 minutes duration. The others ones (V2 to V4) will be about 30 minutes duration. All sessions will be carried out in the Pneumology Department of the Foch Hospital, volatolomics platform (Exhalomics®). Exhalation collection will be performed at each visit in order to perform the volatolom analysis.

Conditions

• Chronic Obstructive Pulmonary Disease Severe

Interventions

Type	Name	Description
DEVICE	VOC analysis	VOC analysis in exhaled air with e-noses and mass spectrometry.

Timeline

• Start date: 2021-10-13
• Primary completion: 2023-06-13
• Completion: 2023-06-13
• First posted: 2021-08-31
• Last updated: 2022-01-28

Locations

1 site across 1 country: France